SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-20-018339
Filing Date
2020-08-13
Accepted
2020-08-13 16:36:24
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10014377_10q.htm 10-Q 776653
2 EXHIBIT 31.1 brhc10014377_ex31-1.htm EX-31.1 12304
3 EXHIBIT 31.2 brhc10014377_ex31-2.htm EX-31.2 11997
4 EXHIBIT 32.1 brhc10014377_ex32-1.htm EX-32.1 4945
5 EXHIBIT 32.2 brhc10014377_ex32-2.htm EX-32.2 4884
12 image01.jpg GRAPHIC 36958
13 image02.jpg GRAPHIC 28475
  Complete submission text file 0001140361-20-018339.txt   4406731

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pdsb-20200630.xml EX-101.INS 721820
7 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20200630.xsd EX-101.SCH 36678
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20200630_cal.xml EX-101.CAL 39407
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20200630_def.xml EX-101.DEF 157693
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20200630_lab.xml EX-101.LAB 579422
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20200630_pre.xml EX-101.PRE 310394
Mailing Address 25B VREELAND ROAD FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 201099830
SIC: 2834 Pharmaceutical Preparations